CAVA 集团
CAVA
57.25
+1.85
+3.34%
CAVA 集团
US · CAVA
#1881 按市值排名
上市于 2023
57.25
+1.85
+3.34%
实时 - 追踪5344个代码 - 心跳于502秒前
· 2026-10-16 19:57
最新新闻
-
Emyria Taps Former U.S. VA Secretary Shulkin to Bolster U.S. Psychedelic StrategyTipRanks · 2026/10/6
-
Orthocell Wins U.S. Defence and VA Access for Remplir Nerve Repair DeviceTipRanks · 2026/4/15
-
On Aug 20, Personalis Received A New Task Order Under Its Contract With U.S. Department Of Veterans Affairs For VA MVP; New Task Order Effective Sept 30, 2026, Valued Up To $18.30MBenzinga · 2026/8/21
-
Emyria Taps Former U.S. VA Secretary Shulkin to Drive U.S. Psychedelic StrategyTipRanks · 2026/9/21
-
公司公告
8-K: U.S. Medicine Magazine Spotlights CyPath® Lung as Promising Tool to Improve Lung Cancer Detection in Veterans, Lower Costs to the VASEC · 2025/9/4
-
Tactile Medical Enters Exclusive U.S. Distribution Agreement With ElastiMed for Its MyoSleeve Wearable Compression Device for VA and DoD PatientsGlobeNewswire · 2026/7/13
新闻标题为自动聚合内容,未经我们团队独立核实或编辑。
报价时间 2026-10-16 19:57:42 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
CAVA 集团 讨论区 0 条评论